FIELD: medicine.
SUBSTANCE: 7-30 days prior to ultra-violet solar radiation (UVSR) exposure patient is introduced with effective amount of composition containing natural lykopin, and one or more carotinoids chosen of phytoene, phytofluene or their mixtures. The specified composition can be used in the form of oral dosed form containing 5 to 15 mg natural lykopin, 0.5 mg to 3.5 mg phytoene and/or phytofluene, 1.5 to 8 mg vitamin E. The specified composition is introduced as pharmaceutical preparation, food or drink.
EFFECT: provide improved component bioavailability and synergism concerning skin protection from UVSR at safe application.
9 cl, 1 dwg, 2 ex
